Advanced Accelerator Applications
id:
advanced-accelerator-applications-162-1327011
title:
Advanced Accelerator Applications
text:
Advanced Accelerator Applications is a France-based pharmaceutical group, specialized in the field of nuclear medicine. The group operates in all three segments of nuclear medicine to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases. In late October 2017, Reuters announced that Novartis would acquire the company for $3.9 billion, paying $41 per ordinary share and $82 per American depositary share representing a 47 percen
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Advanced_Accelerator_Applications
date created:
2014-04-07T15:19:32Z
date modified:
2024-08-27T20:03:37Z
main entity:
{"identifier":"Q16824303","url":"https://www.wikidata.org/entity/Q16824303"}
image:
fields total:
13
integrity:
14